ArticleAnnals of clinical and translational neurology2026

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.

Lea Gerischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.